Case Studies from across the Catapults
- Skills (11),
- Levelling up (18),
- Highlights (27),
- Equality, Diversity and Inclusion (12),
- International (12),
- Academic engagement (19),
- Net Zero (23),
- Health (18),
- Digital technologies (18),
- Business growth (29),
- Supply chains (6),
- Leveraging Investment (19),
Themes
- Cross-Catapult (2),
- Cell and Gene Therapy (17),
- Compound Semiconductor Applications (12),
- Connected Places (15),
- Digital (15),
- Energy Systems (16),
- High Value Manufacturing (18),
- Medicines Discovery (14),
- Offshore Renewable Energy (16),
- Satellite Applications (15),
Catapults (Reset)
Medicines Discovery
Case Study
Bolstering the North West’s position as a life science powerhouse
Medicines Discovery Catapult is driving the levelling up agenda in the North West of England, supporting the region’s fast-growing and increasingly significant life science industry.
Medicines Discovery
Case Study
Transforming UK medical imaging
The Medicines Discovery Catapult is working to ensure the UK remains a world leader in Positron Emission Tomography (PET) Imaging, a data-rich non-invasive imaging modality that offers huge potential across the life sciences and is highly amenable to advances in AI.
Medicines Discovery
Case Study
Alchemab Therapeutics secures private funding for new treatments following collaboration
In 2021 Alchemab and Medicines Discovery Catapult (MDC) collaborated on a Huntington’s disease focussed project, which supported Alchemab in securing significant private investment.
Medicines Discovery
Case Study
The Psychiatry Consortium – exploring new treatments for mental health conditions
Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.
Medicines Discovery
Case Study
International biobank provides database for cancer researchers worldwide
Medicines Discovery Catapult collaborated with Manchester University to create a sustainable model for a biorepository providing a critical data for researchers investigating patient side-effects from radiotherapy.
Medicines Discovery
Case Study
Innovative treatments for a longer healthy, independent life
Figures show that we are spending more of our lives in poor health. In response, a national network is bringing together scientific expertise from across the UK to shed new light on the ageing process and help us stay healthy for longer.
Medicines Discovery
Case Study
Mobilising national high scale COVID-19 testing
In March 2020, the UK government announced the launch of a national testing effort to support the UK’s fight against coronavirus via the establishment of a network of high-scale testing laboratories, known as “Lighthouse Labs”.
Medicines Discovery
Case Study
Developing new treatments to prevent thrombosis
LUNAC Therapeutics, a UK based drug discovery company, together with the Medicines Discovery Catapult and the University of Leeds, are working on the development of an innovative first-in-class anticoagulant treatment drug with minimal bleeding risk.
Page 1 of 1